Editorial · 30 Dec 2025
Research articlePublished 18 Jun 2015
CRYSTALLOGRAPHIC CHARACTERIZATION OF TRANS ESTERIFIED POTENTIAL IMPURITY OF CANDESARTAN
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The title compound (CDC II), C28H28N6O3, is a potential impurity found in commercial product candesartan cilexetil, consist of N- ethylation of tetrazole moiety attached to biphenyl ring, selectively at N-6 position. The Crystal structure held together by CHO intermolecular interactions. Crystal structure of the title compound was obtained by single crystal X-ray diffraction which was crystallizes in the monoclinic space group P21/n with cell parameter a = 12.1574(12)Å, b = 13.9178(14)Å,c = 15.9742(19)Å and Z = 4.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Research and Development in Pharmacy & Life Sciences.
Short communication · 30 Dec 2025
Advancements in Life Sciences for Disease Treatment
Editorial · 30 Dec 2025
Enhancing Drug Bioavailability Through Advanced Formulation Design
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Research and Development in Pharmacy & Life Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kartik S. Renalson”
- BylineArticles whose byline prints “Ashok B. Kalambe”
- BylineArticles whose byline prints “Deepa Y. Panhekar”
- BylineArticles whose byline prints “Rakeshwar Bandichhor”